| INAB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the INAB market cap history going back to 9/7/2021:
Also see: INAB Shares Outstanding History and INAB YTD Return |
As of 8/3/2026 IN8bio has a market cap of 9.46 million. Investors often follow the INAB market cap history to compare the size of the company over time.
This page shows INAB market capitalization trends over time, with 20 market cap datapoints presented, dating back to 9/7/2021.

| INAB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the INAB market cap history going back to 9/7/2021:
Also see: INAB Shares Outstanding History and INAB YTD Return |
| INAB Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||
INAB Historical Market Cap: -44.27% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| INAB Stock Price Chart |
| About IN8bio Inc |
| IN8bio, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T cells that possess properties, including the ability to differentiate between healthy and diseased tissue. Co.'s lead program, INB-400, is in a Phase II clinical trial in which autologous, genetically modified gamma-delta T cells are assessed in glioblastoma (GBM). We show 20 historical shares outstanding datapoints in our INAB shares outstanding history coverage, used to compute INAB market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing INAB market cap history over the course of time is important for investors interested in comparing INAB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of INAB versus a peer is one thing; comparing INAB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like INAB can fluctuate over the course of history. With this page we aim to empower investors researching INAB by allowing them to research the INAB market cap history. |
| INAB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| INAB Share Performance |
| Market Cap Peers |
| IN8bio (INAB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
INBS Market Cap History INBX Market Cap History INCY Market Cap History INDP Market Cap History INDV Market Cap History INFI Market Cap History INGN Market Cap History INKT Market Cap History INMB Market Cap History INNT Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.